Lilly's $3.8 Billion Vaccine Bets: A Quiet Shift Now
Lilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Explore proven ways to ensure immediate payment online for your services. Secure your earnings and enhance your cash flow.
15,910 articlesLilly's heavy reliance on GLP-1 drugs has investors watching as the company bets $3.8B on vaccines. This analysis exp...
Is Byrna Technologies the next big opportunity in non-lethal protection? This analysis breaks down the growth case, k...
New York’s Fair and Transparent Real Estate Listings Act clears the Assembly and heads to the Senate, aiming to curb ...
VanEck’s gaming-focused ETF has rebranded to GENZ, shifting to digital-native growth and altering the dividend safety...
California Governor Gavin Newsom alleges political targeting by the DOJ, linking a widening probe to his potential pr...
Choosing between an energy infrastructure ETF and a clean energy fund comes down to income versus growth and risk. Th...
Manchester’s mayor is emerging as Labour’s strongest northern voice in a high-stakes leadership contest. This report ...
Is SpaceX a smarter buy than the Magnificent Seven it briefly rivaled in market value? This analysis weighs growth, p...
Micron burst higher after a strong earnings report, but does micron's improved price truly reflect durable fundamenta...
As AI builds out more data centers, the U.S. power grid faces mounting strain. HPE’s warning of a looming 19 gigawatt...
Micron stock just dropped as traders weigh demand for memory parts against a backdrop of cyclical pricing. This artic...
A U.S. Polo Assn. CEO faced a promotion snub, then outworked every competitor for six months to seize the role and dr...